SEC Form 3 · accession 0001567619-19-002401
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian JG Pereira
Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No Securities are beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List - Exhibit 24.1 - Power of Attorney